Cover
Cover | Sep. 26, 2024 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Sep. 26, 2024 |
Entity File Number | 000-22245 |
Entity Registrant Name | Seelos Therapeutics, Inc. |
Entity Central Index Key | 0001017491 |
Entity Tax Identification Number | 87-0449967 |
Entity Incorporation, State or Country Code | NV |
Entity Address, Address Line One | 300 Park Avenue |
Entity Address, Address Line Two | 2nd Floor |
Entity Address, City or Town | New York |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 10022 |
City Area Code | 646 |
Local Phone Number | 293-2100 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.001 par value |
Trading Symbol | SEEL |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |